Humanigen Inc
Humanigen Inc
HGEN

Humanigen Inc (HGEN)

$1.773.8%

  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$1.72
Day's Range
$1.9893
$1.67
52-Week Range
$18.68
1 month return13.66%
3 month return46.85%
1 year return89.18%
5 year return81.66%

Company Information

Humanigen, Inc. is developing its portfolio of Humaneered® monoclonal antibodies to address cutting-edge CAR-T optimization and oncology treatments advancing safer, better, and more effective cancer therapies. Derived from the company's Humaneered® platform, lenzilumab and ifabotuzumab are monoclonal antibodies with first-in-class mechanisms. Lenzilumab, which targets GM-CSF, is in development as a potential biologic therapy to make CAR-T therapy safer and more effective, as well as a potential treatment for rare hematologic cancers such as CMML and JMML. Ifabotuzumab, which targets the Eph type-A receptor 3 (EphA3), is being explored as a potential treatment for glioblastoma multiforme (GBM) and other deadly cancers, both as naked antibody and as part of an antibody-drug conjugate, as well as a backbone for a novel CAR-T construct, and a bispecific antibody platform.
OrganizationHumanigen Inc
Employees10
CEOCameron Durrant
IndustryBiotechnology

Analyst Recommendation

based on 14 analysts ratings

Buy
64%
Buy
28%
Hold
7%
Sell

Based on 14 Wall street analysts offering stock ratings for Humanigen Inc(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 1237.29%

Current

$1.77

Target

$23.67

Recommendation Trend

Based on 14 analyst

Current1M Ago3M Ago
Buy
9
9
10
Hold
4
4
4
Sell
1
1
1
Consensus
BUY
BUY
BUY

Company Financials

  • Annual
  • Quarterly

Highlights

Market Capitalization
134.4M
Book Value
0.32
Dividend Share
0.0
Dividend Yield
0.0
Earnings Share
-4.04
Wall Street Target Price
19.88

Valuation

Trailing PE0.0
Forward PE9.39
Price/Sales (ttm)
37.39
Price/Book (mrq)
9.2
Enterprise Value
100.0M
Enterprise Value/Revenue
27.81
Enterprise Value/Ebitda
0.0

Technicals

Beta
-1.47
50 Day MA
2.66
200 Day MA
6.83

Institutional Holdings

Valiant Capital Management LP

9.75%

Murchinson Ltd.

6.37%

BlackRock Inc

4.73%

Vanguard Group Inc

3.44%

State Street Corporation

1.77%

Marshall Wace Asset Management Ltd

1.52%

Discover more

Frequently Asked Questions

What is Humanigen Inc share price today?

Can Indians buy Humanigen Inc shares?

How can I buy Humanigen Inc shares from India?

Can Fractional shares of Humanigen Inc be purchased?

What are the documents required to start investing in Humanigen Inc stocks?

What are today’s High and Low prices of Humanigen Inc?

What are today’s traded volumes of Humanigen Inc?

What is today’s market capitalisation of Humanigen Inc?

What is the 52 Week High and Low Range of Humanigen Inc?

How much percentage Humanigen Inc is down from its 52 Week High?

How much percentage Humanigen Inc is up from its 52 Week low?

What are the historical returns of Humanigen Inc?

Who is the Chief Executive Officer (CEO) of Humanigen Inc?